Citigroup
TXG icon

Citigroup’s 10x Genomics TXG Stock Holding History

Citigroup’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,200
Closed -$773K – 5866
2022
Q4 		$773K Buy
+21,200
New +$693K ﹤0.01% 2855
2022
Q3 		– Sell
-120,200
Closed -$5.44M – 6332
2022
Q2 		$5.44M Buy
120,200
+58,600
+95% +$3.04M ﹤0.01% 1489
2022
Q1 		$4.69M Buy
61,600
+34,600
+128% +$3.03M ﹤0.01% 1709
2021
Q4 		$4.02M Buy
+27,000
New +$4.14M ﹤0.01% 2008

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's TXG Position: Q1 2026 in Review

Citigroup reduced its 10x Genomics (TXG) stake by 63% in Q1 2026, selling an estimated $1.71M and leaving 50,475 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

Citigroup first reported a position in TXG in Q4 2019 and has held it in 26 quarters since. The position peaked at $18.1M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Citigroup held 50,475 shares of 10x Genomics worth $1.07M as of Q1 2026.
  • Citigroup sold 85,480 10x Genomics shares in Q1 2026, an estimated $1.71M.
  • 10x Genomics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3074 holding.
  • Citigroup first reported a position in 10x Genomics in Q4 2019 and has held it in 26 quarters since.
  • Citigroup's 10x Genomics position peaked at $18.1M in Q2 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.